Not an actual patient.
treating patients with RMS globally, and counting1,a
globally for RMS with the established therapy of TYSABRI, and counting1,b
currently prescribed in the US have been on TYSABRI for more than 5 years1
in the US who start TYSABRI have received no previous DMT1,c
a1,068,044 patient-years of experience as of January 2023.1 b257,071 patients treated as of January 2023.1 c37.7% of patients as of April 2021.1